The management of patients who have CNS infections is challenging. Therapy for CNS infections is evolving in light of changing microbial resistance patterns and with the introduction of new antimicrobial agents. Knowledge of cerebral inflammation, molecular diagnostics, and the evolving microbial epidemiology are important to optimizing therapy in patients with meningitis. Future investigations into the role of selective immunomodulation and other neuroprotective strategies may lead to significant advances in the management of CNS infection.
|Original language||English (US)|
|Number of pages||34|
|Journal||Critical care clinics|
|State||Published - Oct 2006|
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine